What is the management approach for infiltrative disease in the eyes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Infiltrative Disease in the Eyes

The management of infiltrative disease in the eyes requires a systematic diagnostic approach followed by targeted treatment based on the specific etiology, as infectious and non-infectious causes require fundamentally different therapeutic strategies. 1

Diagnostic Approach

Initial Assessment

  • Slit-lamp examination: Evaluate for:
    • Location, density, size, shape, depth, and character of infiltrate margins
    • Presence of epithelial defects
    • Signs of stromal ulceration, thinning, or perforation
    • Anterior chamber reaction (cells, flare, hypopyon)
    • Evidence of previous inflammation or surgery 1

Diagnostic Testing

  1. Cultures and smears are indicated when:

    • Infiltrate is central, large (≥2mm), or has significant stromal involvement
    • Multiple corneal infiltrates are present
    • Anterior chamber shows ≥1+ cells
    • History of corneal surgery exists
    • Atypical features suggesting fungal, amoebic, or mycobacterial infection
    • Poor response to empiric therapy 1
  2. Advanced imaging:

    • Scanning laser confocal microscopy: Particularly useful for identifying Acanthamoeba, fungal, and bacterial keratitis
    • Optical coherence tomography: Helps determine depth of involvement
    • Ultrasound biomicroscopy: For assessing intraocular structures when severe keratitis is present 1
  3. Corneal biopsy when:

    • Response to treatment is poor
    • Repeated cultures are negative despite clinical suspicion
    • Infiltrate is located in mid or deep stroma with overlying uninvolved tissue 1

Differential Diagnosis

Infectious Causes

  • Bacterial keratitis: Often suppurative appearance
  • Fungal keratitis: Dry appearance, feathered edge, satellite lesions, posterior plaque
  • Acanthamoeba keratitis: Ring infiltrate, radial keratoneuritis, severe pain
  • Viral keratitis: HSV, VZV, Epstein-Barr virus (may have dendrites or immunologic infiltrates) 1

Non-infectious Causes

  • Contact lens-related: Particularly with extended-wear lenses
  • Systemic autoimmune diseases: Rheumatoid arthritis, lupus, vasculitic disorders, sarcoidosis
  • Dermatologic disorders: Severe ocular rosacea
  • Allergic conditions: Vernal keratoconjunctivitis, atopic keratoconjunctivitis
  • Trauma-related: Chemical/thermal injury, foreign bodies, exposed sutures 1

Treatment Algorithm

1. Infectious Keratitis

Bacterial Keratitis

  • Initial therapy: Broad-spectrum topical antibiotics
    • For small peripheral infiltrates: Fluoroquinolones or combined fortified antibiotics
    • For large/central/sight-threatening infiltrates: Fortified antibiotics (cefazolin + tobramycin/gentamicin)
  • Frequency: Every 30-60 minutes initially, then taper based on clinical response
  • Adjust therapy based on culture results and clinical response 1

Fungal Keratitis

  • Topical antifungals: Natamycin 5% for filamentous fungi, amphotericin B for yeasts
  • Consider systemic antifungals for deep or severe infections
  • Longer treatment course (weeks to months) typically required 1

Acanthamoeba Keratitis

  • Combination therapy: Polyhexamethylene biguanide (PHMB) or chlorhexidine plus propamidine isethionate
  • Extended treatment often necessary (3-6 months) 1

Viral Keratitis

  • HSV/VZV: Topical and/or oral antiviral agents
  • Monitor for superinfection in patients with epithelial defects or severe disease 1

2. Non-infectious Infiltrative Disease

Autoimmune/Inflammatory

  • Topical corticosteroids: After ruling out infection
  • Systemic immunosuppression: For associated systemic disease or severe cases
  • Treat underlying condition if identified 2

Contact Lens-Related

  • Discontinue contact lens wear
  • Consider prophylactic antibiotics if epithelial defect present
  • Patient education on proper contact lens care 1

Monitoring and Follow-up

  • Frequent follow-up for all infiltrative disease (daily to weekly initially)
  • Document size of infiltrate and epithelial defect at each visit
  • Adjust treatment based on clinical response
  • Consider corneal biopsy if worsening despite appropriate therapy 1

Prevention Strategies

  • Contact lens education: Proper care, avoiding overnight wear
  • For therapeutic bandage lenses: Consider prophylactic antibiotics
  • Patient awareness of warning signs requiring immediate attention (redness, pain, photophobia)
  • Regular follow-up for patients with chronic ocular surface disease 1

Common Pitfalls and Caveats

  1. Misdiagnosis: Clinical appearance alone is insufficient to differentiate bacterial from fungal keratitis (correct in <70% of cases) 1

  2. Delayed cultures: Obtain cultures before starting antimicrobial therapy for sight-threatening infiltrates

  3. Inappropriate steroid use: Never use steroids without ruling out infection first

  4. Overlooking systemic disease: Always consider potential systemic associations, especially with bilateral or recurrent infiltrates 2

  5. Inadequate follow-up: Infiltrative disease requires close monitoring until resolution

  6. Underestimating severity: Central infiltrates or those with anterior chamber reaction require aggressive management 1

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.